BACKGROUND The cardiac natriuretic peptides (NPs), atrial natriuretic peptide (ANP) and B-type natriuretic peptide
T he heart synthesizes a family of hormones known as natriuretic peptides (NPs), which includes atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP). These molecules promote renal sodium excretion and arterial vasodilation, and inhibit cardiac hypertrophy (1) (2) (3) . Recent studies suggest that NPs have a wide range of favorable metabolic effects as well, including activation of brown fat (4) , lipolysis, and improvement in skeletal muscle oxidative capacity (5) .
Obese individuals have unexpectedly low NP levels (6) . It has been proposed that a "relative NP deficiency" predisposes obese individuals to salt retention, hypertension, and glucose intolerance. Thus, understanding the chronic and acute factors that contribute to reduced NP levels in obese individuals holds important implications (7) (8) (9) . Because the reduction in NP levels is particularly prominent among those with insulin resistance and hyperinsulinemia, we investigated whether a high dietary glucose load can acutely suppress circulating NP concentrations. Such a response would be a disadvantage in obese individuals who have lower NP levels to begin with, thereby contributing to a "vicious cycle" of impaired fat and glucose metabolism.
The objectives of this study were to: 1) assess the acute effects of a carbohydrate challenge on NP levels in healthy subjects; 2) determine whether there is a difference in the magnitude of change in NPs in lean versus obese individuals; and 3) investigate potential mechanisms linking hyperglycemia and reduced NP levels.
As part of the third objective, we investigated the role of micro ribonucleic acid (miRNA)-425 (miR-425), a recently discovered negative regulator of ANP (10) . miRNAs are noncoding RNAs, which repress messenger RNA (mRNA) translation and/or stability by binding to partially complementary sequences in target mRNAs, typically in the 3 0 untranslated region (3 0 UTR) (11) . We have shown that miR-425 interacts with the 3 0 UTR of NPPA to repress NPPA mRNA levels and the secretion of N-terminal proANP (NT-proANP) from human cardiomyocytes (10) . The regulation of miR-425 expression is largely unexplored; however,
Ma and colleagues reported that in human cancer cells, the expression of miR-425 is up-regulated by the transcription factor nuclear factor kappa B (NF-kB) (12) . In addition, the expression and activity of NF-kB are increased in vascular smooth muscle cells and endothelial cells in the presence of high glucose (13) (14) (15) Mixed effect models incorporating all nonmissing data from 33 study subjects were used to assess the effects of time and carbohydrate challenge and their interaction on plasma NT-proANP and NT-proBNP levels.
For mRNA, the primary transcript of miRNA (pri-miRNA), and miRNA levels, we performed 2-sample or paired Student t tests, as appropriate. All analyses were conducted using SAS Version 9.4 software (SAS Institute, Cary, North Carolina).
A 2-sided p < 0.05 was considered statistically significant. Student t tests are reported without adjustments for multiple comparisons.
RESULTS
Characteristics of the study sample are shown in Table 1 . The mean AE SD systolic blood pressure (BP) for our study participants was 112 AE 8 mm Hg and Figure 1A ). At baseline, mean plasma insulin levels were 5 AE 2 mIU/ml in lean versus 9 AE 4 mIU/ml in overweight or obese individuals. After the carbohydrate challenge, peak insulin levels increased to 54 AE 26 mIU/ml in lean individuals and to 99 AE 49 mIU/ml in overweight or obese individuals ( Figure 1B) .
Plasma NT-proANP concentrations after overnight fasting are shown according to BMI in Figure 2A .
Lean individuals had 28% higher plasma levels of In contrast to NT-proANP, plasma NT-proBNP levels did not change after the carbohydrate challenge ( Figure 2B ).
GLUCOSE EFFECTS ON miR-425 AND NPPA mRNA LEVELS. As the acute change in plasma NP levels appeared to be restricted to ANP, we performed further studies with a focus on miR-425, a negative regulator of ANP production (10) . First, we investigated whether glucose treatment of human cardiomyocytes increased miR-425 expression levels.
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Metabolic Influences on Natriuretic Peptides The solid line with squares represents lean subjects, and the dotted line with circles represents overweight or obese subjects. Data are expressed as mean AE SEM.
BMI ¼ body mass index. 
DISCUSSION
In this study, we demonstrated that a high carbohydrate intake acutely decreases circulating NTproANP levels in humans. We provided evidence that the underlying mechanism appears to involve the induction of NF-kB by glucose, leading to increased expression of miR-425, a negative regulator of NPPA (Central Illustration). These clinical and experimental findings elucidate a novel mechanism for acute metabolic regulation of the NP axis, which may have important physiologic implications given the role of the NP system in cardiovascular homeostasis.
We and others have previously reported that low NP levels are particularly prevalent among that there could be chamber-specific differences in the expression levels of GLUT4 (glucose transporter type 4), the major glucose transporter expressed in the heart (25).
In our in vivo studies, we fasted the NPPA tg/þ mice for 16 h before glucose administration, rather than for shorter periods of time, to reduce competition for glucose utilization from long-chain fatty acids, the main source of energy in the heart (26).
Glucose and fatty acids compete for usage by the heart, depending on the concentrations of either substrate in the body, and reciprocally inhibit the usage of the other. A 16-h fast increased the probability that fat stores in the mice would have been depleted, resulting in significantly diminished levels of circulating fatty acids.
CONCLUSIONS
We identified a novel mechanism whereby diet may influence the cardiovascular system in an acute manner. Our findings suggest that the induction of miR-425 levels in response to glucose leads to reduced ANP levels after a carbohydrate challenge.
The NPs exert a range of beneficial actions, including reduction in BP, salt excretion, activation of brown fat, and increased energy expenditure. Thus, Abbreviations as in Figure 5 .
Metabolic Influences on Natriuretic Peptides A high glucose load stimulates nuclear factor kappa B (NF-kB) signaling, which induces the expression of micro ribonucleic acid 425 (miR-425), a negative regulator of atrial natriuretic peptide (ANP) production, in cardiomyocytes. Suppression of ANP production could have adverse short-and long-term cardiometabolic consequences, because ANP plays a role in blood pressure reduction, salt excretion, activation of brown fat, and increased energy expenditure. mRNA ¼ messenger ribonucleic acid; NP ¼ natriuretic peptide; pri-miR-425 ¼ primary transcript of miR-425; UTR ¼ untranslated region. Metabolic Influences on Natriuretic Peptides
